Work

Abstract 5726: QLS1103, A highly potent and selective PARP7 inhibitor treating advanced solid tumors

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-5726

Authors: Yuxing Zhang, Xiaoxia Yan, Yiming Xu, Difei Dong, Huijie Guo, Junguo Hao, Xinrui Shao, Ling Li, Guanxin Huang, Dong Yang, Guqin Shi, Yanling Xu, Daqing Sun, Weimei Sun, Weikang Tao

Institution: Qilu Pharmaceutical Co., Ltd. (China)

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409638304

Cites:

Cited by:

Related to: 10